← feed

Is NCT02993237 results overdue?

Yes — results are overdue. Primary completion was 2017-05-25; the FDAAA-801 reporting deadline (2018-05-25) passed 2949 days ago and no results are posted on ClinicalTrials.gov.

Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets

NCT IDNCT02993237 ↗
SponsorJanssen Research & Development, LLC (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-05-25 (ACTUAL)
Reporting deadline2018-05-25 (completion + 365d)
Days overdue2949
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 828fd9d4e8053536… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02993237. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →